Grifols, S.A.
GRFSNASDAQHealthcare● Active
$7.33
$-0.31(-4.06%)
Market Cap$6.2B
P/E Ratio—
52W High$11.14
52W Low$7.33
Grifols, S.A.（GRFS）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · GRFS · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $0.39B | $0.44B | $0.21B | $0.36B | $0.19B |
| Depreciation & Amort. | $0.43B | $0.44B | $0.45B | $0.41B | $0.36B |
| Stock-Based Comp. | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Change in Working Capital | ($0.02B) | $0.02B | ($0.36B) | ($0.61B) | ($0.18B) |
| Net Cash from Operations | $1.01B | $0.90B | $0.22B | ($0.01B) | $0.60B |
| Investing Activities | |||||
| Capital Expenditure | ($0.25B) | ($0.37B) | ($0.31B) | ($0.38B) | ($0.25B) |
| Purchases of Investments | ($0.05B) | ($0.04B) | ($0.09B) | ($0.16B) | $0.00B |
| Sales of Investments | $0.00B | $0.00B | $0.02B | $0.00B | $0.00B |
| Net Cash from Investing | ($0.56B) | $0.89B | ($0.39B) | ($1.98B) | ($0.85B) |
| Financing Activities | |||||
| Common Stock Repurchased | ($0.12B) | $0.00B | $0.00B | ($0.00B) | ($0.13B) |
| Dividends Paid | ($0.12B) | ($0.00B) | $0.00B | ($0.00B) | ($0.25B) |
| Debt Issued / Repaid | ($0.18B) | ($0.11B) | ($0.12B) | ($0.10B) | $2.75B |
| Net Cash from Financing | ($0.51B) | ($1.36B) | $0.17B | ($0.17B) | $2.30B |
| Free Cash Flow | |||||
| Free Cash Flow | $0.75B | $0.53B | ($0.09B) | ($0.39B) | $0.35B |
| FCF Margin %(computed) | 10.39% | 7.36% | -1.39% | -6.37% | 7.09% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · EUR · B
深入了解Grifols, S.A.
关于Grifols, S.A.（GRFS）现金流量表
Grifols, S.A. 2025财年经营活动现金流$1.01B，自由现金流$0.75B（FCF利润率10.39%），资本支出($0.25B)。
常见问题
GRFS · 4 问Grifols, S.A. 2025财年自由现金流$0.75B，同比up41.5%。
GRFS free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10